RRC ID 44866
著者 Nakagawa Y, Nakayama H, Nagata M, Yoshida R, Kawahara K, Hirosue A, Tanaka T, Yuno A, Matsuoka Y, Kojima T, Yoshitake Y, Hiraki A, Shinohara M.
タイトル Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
ジャーナル Int J Oncol
Abstract The tumor-associated microenvironment has been shown to protect tumor cells from treatment, and the extracellular matrix (ECM) is known to affect drug resistance as a key regulator of the tumor microenvironment. However, little is known about cell adhesion-mediated drug resistance (CAM-DR) due to cell-ECM contact in patients with oral squamous cell carcinoma (OSCC). In the present study, we evaluated the ECM molecule fibronectin (FN) using DNA microarray data obtained from parental and 5-FU-resistant OSCC cell lines. We investigated the effects of cell adhesion to FN on 5-FU resistance in OSCC cells and examined the activation of FN receptor β1 integrin-mediated survival regulators such as ILK, Akt and NF-κB. In addition, we investigated whether FNIII14, a 22-mer peptide derived from FN that potently prevents β1 integrin-mediated adhesion to FN, could overcome CAM-DR against 5-FU in OSCC cells and examined the activation of survival regulators and apoptosis-related molecules. Consequently, we obtained the following results. FN was extracellularly overexpressed in the 5-FU-resistant cells compared with that observed in the 5-FU-sensitive cells. Cell adhesion to FN enhanced 5-FU resistance and activated integrin-mediated ILK/Akt/NF-κB survival signaling in the 5-FU-resistant OSCC cells. Furthermore, the inhibition of cell adhesion to FN by FNIII14 enhanced chemosensitivity to 5-FU and apoptosis by suppressing ILK/Akt/NF-κB signaling in the 5-FU-resistant cells. These novel findings demonstrate that FN is a potentially useful biomarker and therapeutic target for improving the treatment of OSCC, particularly in the setting of 5-FU resistance.
巻・号 44(4)
ページ 1376-84
公開日 2014-4-1
DOI 10.3892/ijo.2014.2265
PMID 24452447
MeSH Antimetabolites, Antineoplastic / pharmacology Apoptosis / physiology Biomarkers, Tumor Carcinoma, Squamous Cell / drug therapy Cell Adhesion / drug effects Cell Adhesion / genetics* Cell Line, Tumor Drug Resistance, Neoplasm / genetics* Extracellular Matrix / drug effects Fibronectins / biosynthesis Fibronectins / genetics* Fluorouracil / pharmacology* Humans Integrin beta1 / metabolism Mouth Neoplasms / drug therapy* NF-kappa B / metabolism Protein Serine-Threonine Kinases / metabolism Proto-Oncogene Proteins c-akt / metabolism Signal Transduction Tumor Microenvironment
IF 3.899
引用数 27
WOS 分野 ONCOLOGY
リソース情報
ヒト・動物細胞 Ca9-22(RCB1976) SAS(RCB1974)